Home › Resources › Fastest Prop Firm Funding

Fastest Prop Firm Funding in 2026: 1-Step Evals, 1-Day Passes & Instant Funding

Updated July 2026 · ~8 min read

Three routes get you to funded capital: an evaluation you can pass fast, an evaluation with no minimum days, or skipping the evaluation entirely. Here's how the major firms actually compare on time-to-funded in 2026 - and which route fits an automated strategy.

Time-to-funded, side by side

Route 1: The 1-day pass (Apex)

Apex is the only major futures firm where the rulebook allows a genuine single-day pass: 1 minimum trading day and no daily loss limit. A volatile NQ session plus a trend-following strategy can print the $3,000 target on a 50k eval before the close. The cost of that freedom comes later - the funded account adds the contract scaling rule and the 30% consistency rule, so the sprint is the eval, not the payout.

Route 2: No-minimum evals (MFF, Bulenox, TradeDay)

MyFundedFutures, Bulenox, and TradeDay set no minimum trading days, but each enforces a daily loss limit around $1,000-$1,250 on a 50k. In practice the daily limit paces your strategy to 2-3 sessions unless it wins big without drawdown. The upside: MFF's static drawdown and TradeDay's clean rule set are friendlier homes for automation once funded. See the full futures prop firm comparison for the rule-by-rule detail.

Route 3: Instant funding (no eval at all)

Instant funding firms like OFP Funding hand you a funded account at purchase - no target, no phases, no minimum days. The economics flip, though: entry-tier profit splits are far below the 90% evaluation firms pay, and CME futures generally aren't on the menu; OFP runs forex and CFDs on MT5. If that's your market, our OFP Pine Script guide covers how to bridge TradingView signals to an OFP account.

Which route for an automated strategy?

• High-variance futures strategy (NQ/MNQ trend days): Apex. No daily loss limit means one bad morning doesn't end the day, and one great day can end the eval.
• Steady futures grinder ($150-$400/day): MFF, Bulenox, or TradeDay - no artificial day minimums, and the daily loss limit you must code around protects the account anyway.
• Forex/CFD strategy: OFP's instant route, or a 2-step firm like FTMO if you want the higher split and can wait ~8 days.
• Want the most reputable brand and don't mind the pace: Topstep - the 5-winning-day rule caps speed but builds a track record payouts teams like.

FAQ

Which futures prop firm funds traders the fastest?

Apex Trader Funding has the fastest evaluation among major futures firms: a 1-day minimum with no daily loss limit, so a strategy that hits the $3,000 target on a 50k account in one strong session can pass in a single day. MyFundedFutures, Bulenox, and TradeDay have no minimum days at all, but their daily loss limits usually spread the target over several sessions.

What is a 1-step evaluation?

A 1-step (one-phase) evaluation has a single profit target between you and funding - no second verification phase. All the major futures combines (Apex, Topstep, MyFundedFutures, Bulenox, TradeDay) are 1-step. The two-phase model is common at forex/CFD firms like FTMO, where phase one requires roughly 10% and phase two another 5%.

Is instant funding worth it compared to an evaluation?

Instant funding (e.g. OFP Funding) removes the evaluation entirely, but you pay for it twice: higher account prices and a lower profit split on entry tiers. An evaluation firm costs less up front and pays 90%+ once funded. If your strategy is proven, the eval is usually the better economics; instant funding wins when you value certainty of funded status today.

Can automation speed up passing an evaluation?

Yes, within each firm's rules. Every major futures firm allows automated strategies during the evaluation. Automation removes hesitation and enforces the risk limits that fail most manual attempts - a script cannot revenge-trade. The constraint is the rule set, not the speed: on Topstep you still need 5 winning days of $200+; on Apex a single qualifying day can complete the eval.